New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes
The presence of type 2 diabetes acts as an accelerator of cognitive impairment (mild cognitive impairment and later dementia), with a significant impact on the management of the disease and its complications. Therefore, it is recommended to perform an annual evaluation of cognitive function in patie...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:281750 |
| Acceso en línea: | https://ddd.uab.cat/record/281750 https://dx.doi.org/urn:doi:10.3389/fendo.2022.1024794 |
| Access Level: | acceso abierto |
| Palabra clave: | Dementia Type 2 diabetes Mild cognitive impairment Neuropsychological tests Retinal microperimetry |
| id |
ES_477a67d962e02b5c80816df99a62edce |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:281750 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetesCiudin, Andreea|||0000-0001-5622-0203Simó Canonge, Rafael|||0000-0003-0475-3096DementiaType 2 diabetesMild cognitive impairmentNeuropsychological testsRetinal microperimetryThe presence of type 2 diabetes acts as an accelerator of cognitive impairment (mild cognitive impairment and later dementia), with a significant impact on the management of the disease and its complications. Therefore, it is recommended to perform an annual evaluation of cognitive function in patients with diabetes older than 65 years. Current guidelines still recommend the use of the Minimental State Evaluation Test (MMSE) as screening test, but it has a modest sensitivity and specificity for identifying mild cognitive impairment. This represents an important gap because patients with mild cognitive impairment are at risk of progressing to dementia. The neurocognitive diagnosis is based on complex neuropsychological tests, which require specifically trained personnel and are time consuming, making its routine incorporation into daily clinical practice unfeasible. Therefore, at present there are no reliable biomarkers to identify patients with type 2 diabetes at increased risk of developing cognitive impairment. Since the brain and the retina have a common embryological origin, our Research Group, has worked over the last 10 years evaluating the usefulness of the retina as a "window" to the brain. We provided evidence that retinal microperimetry is a simple, feasible and useful tool for screening and monitoring cognitive function in patients with type 2 diabetes. We propose a review of actual tests recommended for screening of cognitive impairment as well as an update of new emerging methods, such as retinal microperimetry.Universitat Autònoma de Barcelona 22022-01-0120222022-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/281750https://dx.doi.org/urn:doi:10.3389/fendo.2022.1024794reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2817502026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| title |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| spellingShingle |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes Ciudin, Andreea|||0000-0001-5622-0203 Dementia Type 2 diabetes Mild cognitive impairment Neuropsychological tests Retinal microperimetry |
| title_short |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| title_full |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| title_fullStr |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| title_full_unstemmed |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| title_sort |
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes |
| dc.creator.none.fl_str_mv |
Ciudin, Andreea|||0000-0001-5622-0203 Simó Canonge, Rafael|||0000-0003-0475-3096 |
| author |
Ciudin, Andreea|||0000-0001-5622-0203 |
| author_facet |
Ciudin, Andreea|||0000-0001-5622-0203 Simó Canonge, Rafael|||0000-0003-0475-3096 |
| author_role |
author |
| author2 |
Simó Canonge, Rafael|||0000-0003-0475-3096 |
| author2_role |
author |
| dc.contributor.none.fl_str_mv |
Universitat Autònoma de Barcelona |
| dc.subject.none.fl_str_mv |
Dementia Type 2 diabetes Mild cognitive impairment Neuropsychological tests Retinal microperimetry |
| topic |
Dementia Type 2 diabetes Mild cognitive impairment Neuropsychological tests Retinal microperimetry |
| description |
The presence of type 2 diabetes acts as an accelerator of cognitive impairment (mild cognitive impairment and later dementia), with a significant impact on the management of the disease and its complications. Therefore, it is recommended to perform an annual evaluation of cognitive function in patients with diabetes older than 65 years. Current guidelines still recommend the use of the Minimental State Evaluation Test (MMSE) as screening test, but it has a modest sensitivity and specificity for identifying mild cognitive impairment. This represents an important gap because patients with mild cognitive impairment are at risk of progressing to dementia. The neurocognitive diagnosis is based on complex neuropsychological tests, which require specifically trained personnel and are time consuming, making its routine incorporation into daily clinical practice unfeasible. Therefore, at present there are no reliable biomarkers to identify patients with type 2 diabetes at increased risk of developing cognitive impairment. Since the brain and the retina have a common embryological origin, our Research Group, has worked over the last 10 years evaluating the usefulness of the retina as a "window" to the brain. We provided evidence that retinal microperimetry is a simple, feasible and useful tool for screening and monitoring cognitive function in patients with type 2 diabetes. We propose a review of actual tests recommended for screening of cognitive impairment as well as an update of new emerging methods, such as retinal microperimetry. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2 2022-01-01 2022 2022-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/281750 https://dx.doi.org/urn:doi:10.3389/fendo.2022.1024794 |
| url |
https://ddd.uab.cat/record/281750 https://dx.doi.org/urn:doi:10.3389/fendo.2022.1024794 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869407297326809088 |
| score |
15,300719 |